Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: TRANSPHORM, INC
Awarding agency: Department of Defense / Department of the Army
Funding agency: Department of Defense / Defense Advanced Research Projects Agency
Period of performance: 2021-09-02 to 2023-11-24
Current total value of award: $919644.84
Description: MODIFICATION P00006 IS FOR A NO COST EXTENSION TO CONTRACT W31P4Q-21-C-0009.